• videocam Live Webinar with Live Q&A
  • calendar_month December 10, 2026 @ 1:00 PM ET/10:00 AM PT
  • signal_cellular_alt Intermediate
  • card_travel Insurance
  • schedule 90 minutes

Insurance Surveillance Pricing: Key Issues, Legislative and Regulatory Responses, and Expanding Scrutiny

Preparing for Unexpected Litigation Over How an Insurer Sets Premiums

About the Course

Introduction

This CLE webinar will help counsel for either policyholders or insurers prepare for unexpected claims and counterclaims arising from the way an insurance policy may have been priced and sold. The panel will offer guidance on distinguishing risk-based pricing, a widely accepted and standard practice in insurance, from non-risk-based pricing, whether referred to as "price optimization," "surveillance pricing," or another similar term.

Description

In the insurance context, price optimization occurs when insurers use customers' non-risk-related behavioral data to set different prices for different customers with identical risk profiles. This non-risk data may include, for example, information indicating who is or is not willing to “shop around” for coverage. Price optimization, also known as surveillance pricing, is not new, but AI has taken it to the next level.

For policyholders and regulators, price optimization has raised concerns about transparency, fairness, and trust in the insurance industry. Several states have prohibited or restricted the practice, and numerous state insurance regulators have issued bulletins addressing it. The Federal Trade Commission (FTC) has also expressed concern. Increasingly, counterclaims or standalone lawsuits, including class actions, allege price optimization constitutes a deceptive and unfair trade practice, violates consumer data privacy laws governing how personal data is collected and used, and violates antitrust laws.

Listen as this experienced panel reviews the current developments regarding insurance price optimization and offers guidance for responding to concerns over transparency, fairness, and consumer trust. 

Presented By

Alexander I. Schneider
Special Counsel
Kelley Drye & Warren LLP

Mr. Schneider helps data-driven businesses with their privacy, data-governance and compliance strategy at all stages, including market entry, rollout of new products, services, and initiatives, due diligence, and corporate transactions. He negotiates and drafts commercial agreements that meet regulatory requirements and protect confidential and personal information, including cloud service, data processing, data integration, AI, and e-commerce agreements. Mr. Schneider offers practical guidance on structuring contracts with AI vendors and addressing the patchwork of regulations when businesses offer or use AI services, chatbots, and automated decision-making technologies. He has extensive experience with a range of federal, state, and global privacy laws, including state privacy laws such as the California Consumer Privacy Act (CCPA), the Colorado Privacy Act (CPA), and the Washington My Health My Data Act, the General Data Protection Regulation (GDPR), the Fair Credit Reporting Act (FCRA), data breach notification laws, biometric privacy laws, the EU ePrivacy Directive and cookie law, the Telemarketing Sales Rule, and global marketing laws.

Credit Information
  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Thursday, December 10, 2026

  • schedule

    1:00 PM ET/10:00 AM PT

I. How pricing and sales disputes may arise in coverage cases 

II. Distinguishing risk-based pricing from "price optimization" 

III. Legislative and regulatory responses to surveillance pricing : impact on litigation

IV. Impact on litigation and defenses

V. Plaintiff strategies

VI. Defense Strategies

The panel will review these and other key issues:

  • Does an insurer need to prove that an AI-generated price reflects legitimate risk rather than automated discrimination or technologically reinforced market exclusion?
  • How are states regulating or prohibiting insurance surveillance pricing?
  • What might be the warning signs that a dispute is moving to pricing?